Polaris Partners Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 28
- Investments
- 890
- Portfolio
- 138
- Exits
- 330
Polaris Partners General Information
Description
Founded in 1996, Polaris Partners is a venture capital firm headquartered in Boston, Massachusetts. The firm prefers to invest in the technology, software, tech-enabled services, and healthcare sectors.
Contact Information
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- One Marina Park Drive
- 10th Floor
- Boston, MA 02210
- United States
+1 (855) 000-0000
Polaris Partners Investments (890)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Kallyope | 15-Feb-2022 | Later Stage VC | 00000 | Drug Discovery | Generating Revenue | 000 00000000 00 |
| 0000000 0000000000 | 09-Feb-2022 | 00000 00000 | 00000 | Biotechnology | Startup | 0000 00000 |
| 00000000 | 03-Feb-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | 000 00000000 00 |
| 00000 00000000000 | 26-Jan-2022 | 0000 | 00000 | Other Healthcare Technology Systems | Generating Revenue | |
| 00000000 | 07-Dec-2021 | 00000 00000 | 00000 | Laboratory Services (Healthcare) | Clinical Trials - General | 0000 000000 00.0 |
| 000000000000 | 01-Dec-2021 | 0000000000 | Education and Training Services (B2B) | Generating Revenue | ||
| 000000000 000000 | 27-Oct-2021 | 00000 00000 | 00000 | Biotechnology | Pre-Clinical Trials | 000 00000000 00 |
| 000000 00000000 | 26-Oct-2021 | 00000 00000 | 0000 | Network Management Software | Generating Revenue | 00000 0000000 |
| Entercoms | 20-Oct-2021 | Buyout/LBO | 00.000 | Business/Productivity Software | Generating Revenue | 00000 00000000 |
| Neumora | 07-Oct-2021 | Early Stage VC | 00000 | Drug Discovery | Clinical Trials - Phase 2 |
Polaris Partners Exits (330)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Amunix Pharmaceuticals | 08-Feb-2022 | Merger/Acquisition | 00.000 |
| 0000000 0000000000 | 01-Feb-2022 | 0000000000 | |
| 0000000 0000000000 | 04-Nov-2021 | 000 | 00000 |
| 0000000000 0000000 | 07-Oct-2021 | 000000000000000000 | |
| 0000000 | 30-Sep-2021 | 000000000000000000 | 00000 |
| 00000 00000000 | 07-Sep-2021 | 000000000000000000 | 00000 |
| 0000 000000 | 01-Sep-2021 | 000000000000000000 | 00.000 |
| 0000000 0000000 | 16-Aug-2021 | 000000000000000000 | 00000 |
| Confluence Technologies | 09-Aug-2021 | Buyout/LBO | 00000 |
| Adagio Therapeutics | 06-Aug-2021 | IPO | 00000 |
Polaris Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Polaris Partners‘s full profile, request access.
Request a free trialPolaris Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialPolaris Partners Team (103)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Harold Friedman | Chief Financial Officer | San Francisco, CA | |||
| Bryce Youngren | Managing Partner | 00 | 0 | 0 | Boston, MA |
| David Barrett | Managing Partner | 00 | 00 | 0 | Boston, MA |
| Terrance McGuire | Co-Founding Partner | 00 | 00 | 00 | Boston, MA |
| Alexandra Cantley Ph.D | Partner | 0 | 0 | 0 | New York, NY |
Polaris Partners Co-Investors (498)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 12 | 0 | 0 |
|
|
| GV | 00 | 0 | 0 |
|
|
| The Invus Group | 00 | 0 |
|
|
|
| EcoR1 Capital | 0 | 0 |
|
|
|
| Alexandria Venture Investments | 0 | 0 | 0 |
|
|